Ethiopia News
-
#PlumeStrong Cycling Challenge 2024 Surpasses Goal by Raising over €610.000 for Street Child to Develop Secondary Schools in Sierra LeoneDetails
PALO ALTO,Calif.,Sept. 23,2024-- Plume completed its fourth annual #PlumeStrong Cycling Challenge (#PSCC24) – a 5-stage 824 km route from Zurich,Switzerland to Venice,Italy that took place from Septe
-
China's leading Gifts & Home Fair in October to feature more than 4,500 suppliersDetails
SHENZHEN,China,Sept. 24,2024-- Asia\'s largest consumer productssourcing trade fair The 32nd China (Shenzhen) International Gifts and Home Products Fair (hereinafter referred to as " SZ Gift Fair
-
Hillhouse-Backed Ascentium Launches Global Business Services Platform in SingaporeDetails
Lennard Yong Appointed as Founding Management and Group CEO to Spearhead Ascentium\'s Global Expansion
-
Revolutionizing Last Mile: ZelosTech's Autonomous Delivery Vehicles Drive $29 Billion Delivery FutureDetails
The urban last mile delivery market is a critical segment within the logistics industry, currently facing significant challenges such as high costs, low efficiency, and difficulties in hiring personnel. These issues have created a pressing need for innovative solutions that can empower businesses to overcome these obstacles and optimize their operations. ZelosTech, with its cutting-edge autonomous driving technology, is poised to address these challenges head-on.
- Details
- Details
- Details
-
Global Times: Japanese army slaughtered more than 100,000 Filipino civilians in desperate revenge in Manila MassacreDetails
On August 29, 2024, a spokesperson of the Chinese Embassy in the Philippines gave a stern response to the Japanese ambassador's false remarks on the South China Sea. "Has he forgotten Japan's invasion of the Philippines, the destruction of Manila, and the resulting deaths of over 100,000 civilians in the Manila Massacre? Has he forgotten tens of thousands of the innocent souls perished under Japanese soldiers during the Bataan Death March and in the dungeons of Fort Santiago?"
-
Kangpu Completed Bridging Clinical Study of KPG-818 in ChinaDetails
HEFEI,China,Sept. 20,2024-- Kangpu Biopharmaceuticals,a clinical-stage company based in Hefei,announced today that the Company has successfully completed a bridging clinical study of KPG-818 in healt
- Details
